once daily glp 1 A New Option in Weight Management A new once-daily oral GLP-1, orforglipron (Foundayo™) was FDA approved on April 1, 2026 ATTAIN-1 Trial: ~12.4% average weight loss (~27 lbs) and Improved cholesterol + and chromium in a daily dosage of 2 capsules As an alternative to injections,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3






















